American Diabetes Association Applauds Senate's Efforts To Reauthorize Special Diabetes Programs
Main Category: DiabetesArticle Date: 08 Mar 2010 - 5:00 PDT
| Patient / Public: | ![]() |
4.5 (2 votes) |
| Healthcare Prof: | ![]() |
The American Diabetes Association applauds today's introduction of Special Diabetes Program legislation in the U.S. Senate. The bill (S. 3058) would reauthorize the Special Diabetes Type 1 Program and the Special Diabetes Program for Indians for 5 years. Each program would receive $200 million per year.
Senator Byron L. Dorgan (D-ND), Chair of the Indian Affairs Committee, and Senator Susan M. Collins (R-ME), Co-Chair of the Diabetes Caucus, are the lead sponsors on the bill.
"This legislation would provide crucial funding for diabetes research, prevention and treatment programs," commented Nash M. Childs, PE, Chair of the Board, American Diabetes Association.
"We thank Senator Dorgan and Senator Collins for their leadership in working to ensure that programs to advance type 1 diabetes research and to prevent and treat diabetes among American Indian and Native Alaskan populations continue."
The Centers for Disease Control and Prevention estimates that type 1 diabetes affects 1.18-2.36 million children and adults in the United States. Nearly 17 percent of American Indians and Alaska Natives have diabetes, the highest prevalence among all U.S. racial and ethnic groups.
The Special Diabetes Type 1 Program has led to important advances in many areas of type 1 diabetes research. Showing an excellent return on federal investment, this research has yielded advances in drug therapies and in halting or reversing diabetic complications.
The Special Diabetes Program for Indians has given Indian health programs and tribal communities critical resources and tools to both prevent and treat diabetes. It funds nearly 400 community-directed programs in nearly all federal recognized tribes in 35 states, allowing local tribes and health programs to set priorities that meet the needs of their people.
The legislation was introduced with strong bi-partisan support. The other original co-sponsors of the Senate bill are Senators Max Baucus (D-MT), Jim Bunning (R-KY), Thad Cochran (R-MS), Mike Crapo (R-ID), Richard J. Durbin (D-IL), Chuck Grassley (R-IA), Orrin Hatch (R-UT),Dan Inouye (D-HI), Mike Johanns (R-NE), Blanche Lincoln (D-AR), Lisa Murkowski (R-AK), Charles E. Schumer (D-NY), Jeanne Shaheen (D-NH), Debbie Stabenow (D-MI) and Mark Warner (D-VA).
Similar legislation was introduced in the U.S. House of Representatives last September by Congressional Diabetes Caucus Co-Chairs and Vice Chairs Rep. Diana DeGette (D-CO), Rep. Mike Castle (R-DE), Rep. Xavier Becerra (D-CA) and Rep. Mark Kirk (R-IL), and the Congressional Native American Caucus Co-Chairs Rep. Tom Cole (R-OK), Rep. Dale Kildee (D-MI). Rep. Zack Space (D-OH), a member of the Congressional Diabetes Caucus, joined the bill as an original co-sponsor as well.
Source
American Diabetes Association
Visit our diabetes section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/181549.php>
APA
http://www.medicalnewstoday.com/releases/181549.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





